Stay updated on Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and the previous Revision: v3.4.1 entry was removed. The updates appear to be administrative page maintenance and do not alter study content or results.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center’s operating status, and updated the site release to v3.4.1 (replacing 3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary option added and metadata labels updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now includes a centralized 'Locations' section listing US sites by state (California, Florida, Georgia, Indiana, Michigan, Ohio, Tennessee, Texas, Virginia) and removes the separate 'X Locations' sections; it also shows the revision tag Revision: v3.3.3.SummaryDifference0.9%

- Check92 days agoChange DetectedThe page shows a new revision label, updating from v3.2.0 to v3.3.2, which appears to be a minor documentation or UI update. There are no evident changes to study content, eligibility, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page.